skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 1,633  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Refined by: Database: Freely Accessible Journals remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A bending breakthrough in dystrophic cardiomyopathy
Material Type:
Article
Add to My Research

A bending breakthrough in dystrophic cardiomyopathy

Disease models & mechanisms, 2024-06, Vol.17 (6) [Peer Reviewed Journal]

ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.050657

Full text available

2
Physiological stress improves stem cell modeling of dystrophic cardiomyopathy
Material Type:
Article
Add to My Research

Physiological stress improves stem cell modeling of dystrophic cardiomyopathy

Disease models & mechanisms, 2024-06, Vol.17 (6) [Peer Reviewed Journal]

2024. Published by The Company of Biologists Ltd. ;2024. Published by The Company of Biologists Ltd 2024 ;ISSN: 1754-8403 ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.050487 ;PMID: 38050701

Full text available

3
Female Alms1-deficient mice develop echocardiographic features of adult but not infantile Alström Syndrome cardiomyopathy
Material Type:
Article
Add to My Research

Female Alms1-deficient mice develop echocardiographic features of adult but not infantile Alström Syndrome cardiomyopathy

Disease models & mechanisms, 2024-05 [Peer Reviewed Journal]

2024. Published by The Company of Biologists Ltd. ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.050561 ;PMID: 38756069

Full text available

4
308 Transcriptional profiles associated with pericarditis in patients with systemic lupus erythematosus (SLE) identify purine metabolism pathway genes as candidate mediators
Material Type:
Article
Add to My Research

308 Transcriptional profiles associated with pericarditis in patients with systemic lupus erythematosus (SLE) identify purine metabolism pathway genes as candidate mediators

Lupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A23-A23 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.21

Full text available

5
Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysis

Open heart, 2024-05, Vol.11 (1), p.e002579 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002579 ;PMID: 38719498

Full text available

6
Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort
Material Type:
Article
Add to My Research

Heterogeneity of right ventricular echocardiographic parameters in systemic lupus erythematosus among four clinical subgroups, as stratified by clinical organ involvement in observational cohort

Open heart, 2024-05, Vol.11 (1), p.e002615 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002615 ;PMID: 38702088

Full text available

7
The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease
Material Type:
Article
Add to My Research

The glucocorticoid receptor acts locally to protect dystrophic muscle and heart during disease

Disease models & mechanisms, 2024-05, Vol.17 (5) [Peer Reviewed Journal]

2024. Published by The Company of Biologists Ltd. ;EISSN: 1754-8411 ;DOI: 10.1242/dmm.050397 ;PMID: 38770680

Full text available

8
Prediction of cardiovascular and renal risk among patients with apparent treatment‐resistant hypertension in the United States using machine learning methods
Material Type:
Article
Add to My Research

Prediction of cardiovascular and renal risk among patients with apparent treatment‐resistant hypertension in the United States using machine learning methods

The journal of clinical hypertension (Greenwich, Conn.), 2024-05, Vol.26 (5), p.500-513 [Peer Reviewed Journal]

2024 Janssen Scientific Affairs, LLC. published by Wiley Periodicals LLC. ;2024 Janssen Scientific Affairs, LLC. The Journal of Clinical Hypertension published by Wiley Periodicals LLC. ;ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/jch.14791 ;PMID: 38523465

Full text available

9
A Deep Learning-Driven Pipeline for Differentiating Hypertrophic Cardiomyopathy from Cardiac Amyloidosis Using 2D Multi-View Echocardiography
Material Type:
Article
Add to My Research

A Deep Learning-Driven Pipeline for Differentiating Hypertrophic Cardiomyopathy from Cardiac Amyloidosis Using 2D Multi-View Echocardiography

arXiv.org, 2024-04

2024. This work is published under http://arxiv.org/licenses/nonexclusive-distrib/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;http://arxiv.org/licenses/nonexclusive-distrib/1.0 ;EISSN: 2331-8422 ;DOI: 10.48550/arxiv.2404.16522

Full text available

10
Characterisation of the octogenarians presenting to the diagnostic heart failure clinic: SHEAF registry
Material Type:
Article
Add to My Research

Characterisation of the octogenarians presenting to the diagnostic heart failure clinic: SHEAF registry

Open heart, 2024-04, Vol.11 (1), p.e002584 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002584 ;PMID: 38663890

Full text available

11
New era in heart failure management: implementing cutting-edge therapies effectively
Material Type:
Article
Add to My Research

New era in heart failure management: implementing cutting-edge therapies effectively

Open heart, 2024-04, Vol.11 (1), p.e002659 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002659 ;PMID: 38589204

Full text available

12
An Optimization Framework to Personalize Passive Cardiac Mechanics
Material Type:
Article
Add to My Research

An Optimization Framework to Personalize Passive Cardiac Mechanics

arXiv.org, 2024-04

2024. This work is published under http://creativecommons.org/publicdomain/zero/1.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;http://creativecommons.org/publicdomain/zero/1.0 ;EISSN: 2331-8422 ;DOI: 10.48550/arxiv.2404.02807

Full text available

13
Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count
Material Type:
Article
Add to My Research

Evaluating the real-world effectiveness of belimumab in patients with SLE using SLE-related laboratory values and rheumatoid arthritis-derived disease activity measures: RAPID3, swollen joint count and tender joint count

Lupus science & medicine, 2024-04, Vol.11 (1), p.e001111 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-8790 ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-001111 ;PMID: 38575172

Full text available

14
Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis
Material Type:
Article
Add to My Research

Outcomes of subsequent pregnancy in women with peripartum cardiomyopathy: a systematic review and meta-analysis

Open heart, 2024-04, Vol.11 (1), p.e002626 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002626 ;PMID: 38569669

Full text available

15
Arrhythmias and cardiac MRI associations in patients with established cardiac dystrophinopathy
Material Type:
Article
Add to My Research

Arrhythmias and cardiac MRI associations in patients with established cardiac dystrophinopathy

Open heart, 2024-04, Vol.11 (1), p.e002590 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002590 ;PMID: 38569668

Full text available

16
Relationship between four insulin resistance surrogates and left ventricular hypertrophy among hypertensive adults: a case-control study
Material Type:
Article
Add to My Research

Relationship between four insulin resistance surrogates and left ventricular hypertrophy among hypertensive adults: a case-control study

Endocrine Connections, 2024-04, Vol.13 (4), p.1-11 [Peer Reviewed Journal]

ISSN: 2049-3614 ;EISSN: 2049-3614 ;DOI: 10.1530/EC-23-0476 ;PMID: 38300820

Full text available

17
Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block
Material Type:
Article
Add to My Research

Prevalence of transthyretin cardiac amyloidosis in patients with high-degree AV block

Open heart, 2024-03, Vol.11 (1), p.e002606 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002606 ;PMID: 38538064

Full text available

18
Multimorbidity in patients with atrial fibrillation
Material Type:
Article
Add to My Research

Multimorbidity in patients with atrial fibrillation

Open heart, 2024-03, Vol.11 (1), p.e002641 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002641 ;PMID: 38508658

Full text available

19
Comparison of troponin and natriuretic peptides in Takotsubo syndrome and acute coronary syndrome: a meta-analysis
Material Type:
Article
Add to My Research

Comparison of troponin and natriuretic peptides in Takotsubo syndrome and acute coronary syndrome: a meta-analysis

Open heart, 2024-03, Vol.11 (1), p.e002607 [Peer Reviewed Journal]

Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2024 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002607 ;PMID: 38508657

Full text available

20
Medication Safety: Analysis Shows PPSV23 Is Not Associated With Higher Risk of Serious Outcomes
Material Type:
Article
Add to My Research

Medication Safety: Analysis Shows PPSV23 Is Not Associated With Higher Risk of Serious Outcomes

Pharmacy times, 2024-03, Vol.90 (3)

Copyright MultiMedia Healthcare Inc. 2024 ;ISSN: 0003-0627 ;EISSN: 2168-7234

Full text available

Results 1 - 20 of 1,633  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (1,265)

Refine My Results

Creation Date 

From To
  1. Before 1989  (16)
  2. 1989 To 1996  (47)
  3. 1997 To 2004  (94)
  4. 2005 To 2013  (336)
  5. After 2013  (1,141)
  6. More options open sub menu

Resource Type 

  1. Articles  (1,510)
  2. magazinearticle  (103)
  3. Reviews  (17)
  4. Reports  (2)
  5. Newspaper Articles  (1)
  6. More options open sub menu

Language 

  1. English  (1,623)
  2. Japanese  (144)
  3. Norwegian  (11)
  4. Spanish  (6)
  5. Chinese  (1)
  6. More options open sub menu

Searching Remote Databases, Please Wait